Extrachromosomal DNA in urothelial carcinoma: mechanisms and clinical applications.
This publication is a focused review on the role of extrachromosomal DNA (ecDNA) in urothelial carcinoma. Key points:...
Genomic landscape and precision therapy in prostate cancer: current status and future directions.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This review article synthesizes current knowledge on the genomic landscape of prostate cancer and its implications for p...
Prostate MRI quality improvement: a Roadmap from the ESUR Prostate MRI Working Group.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This article presents a structured, quality-improvement roadmap to standardise and upgrade prostate MRI practice, with t...
Evaluating synergistic versus additive effects of the triplet regimen in metastatic castration-sensitive prostate cancer: a modeling analysis.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This paper evaluates whether the overall survival benefit seen with the ARASENS triplet regimen (androgen-deprivation th...
[Current Data from the National Registry for Prostate Cancer (ProNAT) by d-uo].
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This publication reports initial results from the German National Prostate Cancer Registry (ProNAT), a prospective, non-...
Genomic landscape and clinical impact of BRCA1/2 pathogenic variants in metastatic castration-resistant prostate cancer.
- Post category:Genitourinary (Prostate, Bladder) System
- Reading time:2 mins read
This retrospective Japanese cohort study evaluated 5,893 men with metastatic castration-resistant prostate cancer to cha...